Press Release | NeoGenomics Laboratories

July 23, 2015

NeoGenomics Reports 18% Revenue Growth and Strong Gains in Adjusted EBITDA

July 22, 2015

NeoGenomics Expands Multimodality Cancer Profile Testing

July 20, 2015

NeoGenomics Launches Germline Cancer Predisposition Testing

June 30, 2015

NeoGenomics Schedules its Q2 2015 Earnings Release for July 23, 2015

June 17, 2015

NeoGenomics Announces New Directors

June 16, 2015

NeoGenomics Set to Join Russell 3000 Index

June 11, 2015

NeoGenomics Reports 27% Revenue Growth Driven by Strong Volume Gains and PathLogic Acquisition

April 23, 2015

NeoGenomics Announces Promotions

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients